Merdad Parsey, Chief Medical Officer at GILEAD SCIENCES, INC. (GILD), sold 553 shares at $85.33 ($47K) on 2022-12-30, disclosed to the SEC on 2023-01-03.
Scheduled sale ($47k) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| GILD | SELL | 2024-10-02 | $168K | — | Filing → |
| GILD | SELL | 2024-09-13 | $1.8M | — | Filing → |
| GILD | SELL | 2024-07-01 | $137K | — | Filing → |